NovoLog Mix 70/30 - Insulin aspart 100 [iU] / mL Injection 3 mL

NDC 00169-3696-19 is also written 00169369619, or 0169-3696-19 (0169369619) in 10-digit form. Reference details for licensed healthcare facility review and verification.

NDC 1100169-3696-19
Product NDC00169-3696
Generic Drug Nameinsulin aspart
Brand NameNovoLog Mix 70/30
ManufacturerNovo Nordisk
Strength100 [iU] / mL
Dosage FormInjection
Drug TypeSubcutaneous
Package Quantity5 Syringe, Plastic
Package Description5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) / 3 mL in 1 SYRINGE, PLASTIC
Active IngredientsInsulin Aspart
Marketing CategoryBLA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

insulin aspart 100 [iU] / mL Injection is tracked under NDC 00169-3696-19 and rolls up into product family 00169-3696. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 5 Syringe, Plastic.
  • Manufacturer: Novo Nordisk.
  • Dosage form: Injection.
  • Family size: 1 indexed presentation.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 4 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative Hubinsulin aspart 100 [iU] / mL Injection 3 mL Syringe5 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Drug Shortage Information

Shortage summary

Documented shortage history shows insulin aspart appeared in shortage postings multiple times since 2021, a repeat pattern that suggests elevated future supply risk.

Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.

This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.

NovoLog Mix 70/30 - Insulin aspart 100 [iU] / mL Injection 3 mL, NDC 00169-3696-19, is a Novo Nordisk 100 [iU] / mL injection presentation packaged as 5 Syringe, Plastic. Historical public shortage information is available for this product reference.

NDC search formats

  • Canonical NDC 11: 00169-3696-19
  • Digits-only NDC 11: 00169369619
  • Possible 10-digit display format: 0169-3696-19 (0169369619)

Helpful product links

  • Search by brand name: NovoLog Mix 70/30
  • NDC 11: 00169-3696-19
  • Product family NDC: 00169-3696
  • VA classification code: HS501
  • VA classification code description: INSULIN
  • CMOP ID: I0759
  • VUID: 4042077
  • UNSPSC code: 51183603
  • Misc. Order Numbers: 725074